Category: FDA

3 10/22/2015

Is 1 in 7 Odds a Breakthrough? Is it Even Promising?

2 10/20/2015

How fast to “cures” and at what cost? Politico forum tilts toward pharma-friendly messaging

2 9/22/2015

What do “breakthrough” and “promising” mean to people?

1 8/21/2015

Roundup of flibanserin – ‘female Viagra’ – approval news; ‘game changer’ to some, ‘monumental bamboozlement’ for others

2 8/13/2015

No “likes” from FDA on Kim Kardashian Instagram post; agency cites Canadian drug manufacturer over missing risk info

9 8/4/2015

21st Century Cures Act: A huge step backward for FDA standards

6/30/2015

Harvard’s Jerry Avorn warns against FDA loosening off-label marketing restrictions

4 6/19/2015

Coverage of FDA’s trans fat decision a high-water mark for health journalism

2 6/10/2015

LDL – Lion King of Surrogate Endpoints – key cholesterol issue this week

10 6/5/2015

Astroturfers rule the day: FDA’s flibanserin reviewers were “emotionally blackmailed” by a slick lobbying campaign